In Brief Ohio State creates Clara D. Bloomfield Center for leukemia outcomes research December 04, 2020Vol.46 No.45
Cancer groups say Trump administration’s drug pricing rule will likely harm patients December 04, 2020Vol.46 No.45By Paul Goldberg
NCI Sharpless: “This is one of the most uncertain budget environments that I think the NCI has ever experienced.” December 04, 2020Vol.46 No.45By Alexandria Carolan
Federate the data: NCI produces master plan for the Childhood Cancer Data Initiative December 04, 2020Vol.46 No.45By Matthew Bin Han Ong
Drugs & Targets FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers November 13, 2020Vol.46 No.43
Drugs & Targets FDA issues guidance to enhance diversity in clinical trials, encourage inclusivity in medical product development November 13, 2020Vol.46 No.43
Drugs & Targets European Commission approves Opdivo + Yervoy with two cycles of chemotherapy for first-line treatment of metastatic NSCLC November 13, 2020Vol.46 No.43
Clinical Roundup Keytruda + Lenvima meet PFS primary endpoint in advanced RCC November 13, 2020Vol.46 No.43
Clinical Roundup KEYNOTE-695 study: Tavo + Keytruda demonstrate 30% ORR in anti-PD-1 checkpoint refractory metastatic melanoma November 13, 2020Vol.46 No.43
